4 results match your criteria: "Institute of Neurology and Neurorehabilitation[Affiliation]"
Phantom limb syndrome: from pathogenesis to treatment. A narrative review.
Neurol Sci
October 2024
Institute of Neurology and Neurorehabilitation, IRCCS San Raffaele, Via Della Pisana 235, 00160, Rome, Italy.
Article Synopsis
- Phantom Limb Syndrome (PLS) is when a person feels pain or sensations from a body part that has been removed, like an arm or leg.
- This happens due to changes in the body and brain after amputation, like nerve damage and sensitivity.
- The article talks about different treatments for PLS, including medications and other methods that don’t involve drugs.
Validation of the Kazakh version of the movement disorder Society-Unified Parkinson's disease rating scale.
Clin Park Relat Disord
January 2024
South Kazakhstan Medical Academy, Department of Neurology, Psychiatry, Rehabilitology and Neurosurgery, Shymkent, Kazakhstan.
Background And Purpose: The International Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is widely used in the assessment of the severity of Parkinson's disease (PD). This study aimed to validate the Kazakh version of the MDS-UPDRS, explore its dimensionality, and compare it to the original English version.
Methods: The validation was conducted in three phases: first, the English version of the MDS-UPDRS was translated into Kazakh and thereafter back-translated into English by two independent teams; second, the Kazakh version underwent a cognitive pretesting; third, the Kazakh version was tested in 360 native Kazakh-speaking PD patients.
Bilateral anterior ischemic optic neuropathy after COVID-vaccination.
Neurol Sci
April 2023
Institute of Neurology and Neurorehabilitation, IRCCS San Raffaele, Rome, Italy.
A glimpse of the genetics of young-onset Parkinson's disease in Central Asia.
Mol Genet Genomic Med
June 2021
Department of Neuromuscular Disorders, Institute of Neurology, University College London, London, UK.
Background: Knowledge of the genetic background of many human diseases is currently lacking from genetically undiscovered regions, including Central Asia. Kazakhstan is the first Central Asian country where the genetic studies of Parkinson's disease (PD) have been emerging since it had become a member of the International Parkinson Disease Genomics Consortium. Here we report on the results of whole-exome sequencing (WES) in 50 young-onset PD (YOPD) cases from Kazakhstan.
View Article and Find Full Text PDF